Study on analgesic effect of rofecoxib on patients with advanced carcinoma / 重庆医科大学学报
Journal of Chongqing Medical University
; (12)2003.
Article
de Zh
| WPRIM
| ID: wpr-572879
Bibliothèque responsable:
WPRO
ABSTRACT
Objective:To study the analgesic effect of rofecoxib on patients with advanced carcinoma.Methods:In a randomized clinical trial,108 pathologically diagnosed cancer patients were treated with rofecoxib(dose 25~50mg/d) and the pain relief was observed among all the patients.Results:Rofecoxib was effective in control of cancer related pain in an oral dose of 25~50mg/day with a total effective rate of 84.26%.The main adverse reactions such as drowsiness,dizziness,nausea,vomiting,discomfort in stomach and constipation were slight.Conclusion:Rofecoxib is effective for relieving cancer related pain with sustained duration and slight in adverse reaction and convenient for administration.
Texte intégral:
1
Indice:
WPRIM
Type d'étude:
Clinical_trials
langue:
Zh
Texte intégral:
Journal of Chongqing Medical University
Année:
2003
Type:
Article